Mylan Loses Challenge To “Authorized” Generics In W.Va. Court
This article was originally published in The Pink Sheet Daily
Executive Summary
Federal judge says 180-day exclusivity period was not intended to prohibit competition from NDA holder.
You may also be interested in...
Mylan And J&J Cut A Deal For Generic Ditropan XL
Mylan could become the authorized generic for the 15 mg dose of the overactive bladder product.
Mylan And J&J Cut A Deal For Generic Ditropan XL
Mylan could become the authorized generic for the 15 mg dose of the overactive bladder product.
J&J Ditropan XL Patent Invalidated In Mylan Suit
Mylan win evens score before W.Va. District Court judge who had previously ruled J&J's Levaquin patents were valid and infringed.